PAPER Panchal K, Tiwari AK
SEARCH RESULTS
346 RESULTS
PAPER Ntamo Y, Samodien E, Muller CJ, Louw J, Chellan N
Popular three-dimensional models: Advantages for cancer, Alzheimer's and cardiovascular diseases.
Tissue Cell. 2020 Aug;65:101367. Epub 2020 Apr 17 PubMed: 32746982PAPER Thal DR, Ronisz A, Tousseyn T, Upadhaya AR, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CA, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith AP, Kumar S, Farrar G, Walter J
Correction to: Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
Acta Neuropathol Commun. 2020 Aug 3;8(1):121. PubMed: 32746942PAPER Işık M, Beydemir Ş
The impact of some phenolic compounds on serum acetylcholinesterase: kinetic analysis of an enzyme/inhibitor interaction and molecular docking study.
J Biomol Struct Dyn. 2020 Aug 4;:1-9. PubMed: 32746727PAPER Park J, Im JJ, Song IU, Kang Y
A Comparison of Memory Beliefs, Cognitive Activity, and Depression Among Healthy Older Adults, Amnestic Mild Cognitive Impairment, and Patient with Alzheimer's Disease.
Ann Geriatr Med Res. 2019 Mar;23(1):16-19. Epub 2019 Mar 31 PubMed: 32743280PAPER Yi SH, Suk SH
Letter to the Editor: Relationship Between Neuropsychiatric Symptoms and Activities of Daily Living in Alzheimer Disease.
Ann Geriatr Med Res. 2018 Mar;22(1):49-50. Epub 2018 Mar 31 PubMed: 32743246PAPER Romagnolo A, Balestrino R, Imbalzano G, Ciccone G, Riccardini F, Artusi CA, Bozzali M, Ferrero B, Montalenti E, Montanaro E, Rizzone MG, Vaula G, Zibetti M, Lopiano L
Neurological comorbidity and severity of COVID-19.
J Neurol. 2020 Aug 4; PubMed: 32749601PAPER Glynn K, O'Callaghan M, Hannigan O, Bruce I, Gibb M, Coen R, Green E, A Lawlor B, Robinson D
Clinical utility of mild cognitive impairment subtypes and number of impaired cognitive domains at predicting progression to dementia: A 20-year retrospective study.
Int J Geriatr Psychiatry. 2021 Jan;36(1):31-37. Epub 2020 Aug 13 PubMed: 32748438PAPER Villoslada P, Baeza-Yates R, Masdeu JC
Reclassifying neurodegenerative diseases.
Nat Biomed Eng. 2020 Aug;4(8):759-760. PubMed: 32747833Andrea Martins
PAPER Hoffmann TJ, Theusch E, Haldar T, Ranatunga DK, Jorgenson E, Medina MW, Kvale MN, Kwok PY, Schaefer C, Krauss RM, Iribarren C, Risch N
A large electronic-health-record-based genome-wide study of serum lipids.
Nat Genet. 2018 Mar;50(3):401-413. Epub 2018 Mar 5 PubMed: 29507422PAPER Wojcik GL, Graff M, Nishimura KK, Tao R, Haessler J, Gignoux CR, Highland HM, Patel YM, Sorokin EP, Avery CL, Belbin GM, Bien SA, Cheng I, Cullina S, Hodonsky CJ, Hu Y, Huckins LM, Jeff J, Justice AE, Kocarnik JM, Lim U, Lin BM, Lu Y, Nelson SC, Park SL, Poisner H, Preuss MH, Richard MA, Schurmann C, Setiawan VW, Sockell A, Vahi K, Verbanck M, Vishnu A, Walker RW, Young KL, Zubair N, Acuña-Alonso V, Ambite JL, Barnes KC, Boerwinkle E, Bottinger EP, Bustamante CD, Caberto C, Canizales-Quinteros S, Conomos MP, Deelman E, Do R, Doheny K, Fernández-Rhodes L, Fornage M, Hailu B, Heiss G, Henn BM, Hindorff LA, Jackson RD, Laurie CA, Laurie CC, Li Y, Lin DY, Moreno-Estrada A, Nadkarni G, Norman PJ, Pooler LC, Reiner AP, Romm J, Sabatti C, Sandoval K, Sheng X, Stahl EA, Stram DO, Thornton TA, Wassel CL, Wilkens LR, Winkler CA, Yoneyama S, Buyske S, Haiman CA, Kooperberg C, Le Marchand L, Loos RJ, Matise TC, North KE, Peters U, Kenny EE, Carlson CS
Genetic analyses of diverse populations improves discovery for complex traits.
Nature. 2019 Jun;570(7762):514-518. Epub 2019 Jun 19 PubMed: 31217584John Ringman on Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
COMMENT Though we have made substantial progress in characterizing the behavior of biochemical and imaging biomarkers in presymptomatic and manifest Alzheimer’s disease, we still need an inexpensive and noninvasive index for the presence of AD pathology and its c
David Knopman on Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
COMMENT This study involved persons with dominantly inherited Alzheimer disease mutations who donated plasma samples. The key finding was that ptau181 levels were elevated in both symptomatic and asymptomatic individuals and, in particular, modeling indicated tha
Suzanne Schindler on Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
COMMENT This paper provides further evidence that plasma ptau181 may be an excellent blood-based biomarker for Alzheimer disease brain pathology and symptomatic status. Interestingly, the investigators found very high intra-individual variation in p-tau181 levels
Current Filters
- Date Range : Jul 2020 to Aug 2020 x